Project description
Bioresorbable implants for craniomaxillofacial anomalies
Craniomaxillofacial (CMF) anomalies present from birth are a significant cause of physiological and psychological stress. CMF anomalies are surgically corrected using implants made from non-resorbable materials such as titanium which cannot grow with the patient and need to be removed at a later stage. The EU-funded AMBIT project aims to develop CMF implants from bioresorbable materials made from magnesium alloys. These novel implants will have certain advantages over titanium-based counterparts including improved healing, enhanced patient quality of life and reduced healthcare costs as no additional surgeries will be required to remove them.
Objective
Congenital anomalies, affecting 6% of all babies, are a major cause of infant mortality and childhood morbidity, of which craniomaxillofacial (CMF) anomalies are often a component part. CMF defects are severely debilitating, where the patient not only suffers physically but also psychologically. CMF implants are used to facilitate and accelerate the healing process upon which a second operation is routinely required to remove these devices as most implants comprise of non-resorbable materials (Titanium-Ti, PEEK), with limited patient-specific customisation, that may lead to stress-shielding, infection or lack of growth, particularly in vulnerable paediatric population. The AMBIT project aims to optimise and customise Bioresorbable Magnesium Implants (BMgI) for CMF applications, to overcome the limitations of current clinical gold-standard non-resorbable Ti-based implants. This action combines my expertise in metallurgy and alloy design with Dr. Eoin O'Cearbhaill’s (UCD Centre for Biomedical Engineering (CBE)) and Dr. Ted Vaughan’s (NUIG) expertise in medical device development, testing and translation. This highly interdisciplinary approach will make a significant contribution to the development of bioresorbable CMF implants that will not only improve the post-operation experiences and lives of CMF implant recipients but ultimately decrease the cost burden on national health systems. Through advanced and well-designed training in research (medical device design, cell-studies for biocompatibility, 3D-Printing) and transferable skills (project management, mentorship, entrepreneurship) that go beyond my current field of specialty, and through the networking opportunities that the host will offer, this action will facilitate my reintegration in Europe, while allowing me to become a research leader in biodegradable Mg alloy design & processing for medical device applications, translating alloy design concepts from ideation to clinical use.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- social sciences economics and business business and management entrepreneurship
- natural sciences chemical sciences inorganic chemistry alkaline earth metals
- engineering and technology mechanical engineering manufacturing engineering additive manufacturing
- medical and health sciences medical biotechnology implants
- engineering and technology materials engineering metallurgy
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
H2020-EU.1.3. - EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions
MAIN PROGRAMME
See all projects funded under this programme -
H2020-EU.1.3.2. - Nurturing excellence by means of cross-border and cross-sector mobility
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
MSCA-IF - Marie Skłodowska-Curie Individual Fellowships (IF)
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) H2020-MSCA-IF-2020
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
4 DUBLIN
Ireland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.